Migration inhibitory factor induces killing of Leishmania major by macrophages: Dependence on reactive nitrogen intermediates and endogenous TNF-α

Journal of Immunology

Volumn 161, Issue 5, 1998, Pages 2383-2390

  Jüttner, Stefan ^a   Bernhagen, Jürgen ^b   Metz, Christine N ^c   Röllinghoff, Martin ^a   Bucala, Richard ^c   Gessner, André ^a,d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF STUTTGART   (Germany)

^c PICOWER INST FOR MEDICAL RESEARCH   (United States)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; MIGRATION INHIBITION FACTOR; NITRIC OXIDE SYNTHASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; LEISHMANIA MAJOR; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; LEISHMANIA MAJOR; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032167393     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Bloom, B. R., and B. Bennett. 1966. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80.
2. David, J. 1966. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56:72.
3. Bernhagen, J., T. Calandra, R. A. Mitchell, S. B. Martin, K. J. Tracey, W. Voelter, K. R. Manogue, A. Cerami, and R. Bucala. 1993. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756.
4. Nishino, T., J. Bernhagen, H. Shiiki, T. Calandra, K. Dohi, and R. Bucala. 1995. Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol. Med. 1:781.
5. Tampanaru-Sarmesiu, A., L. Stefaneanu, K. Thapar, K. Kovacs, T. Donnelly, C. N. Metz, and R. Bucala. 1997. Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas. Arch. Pathol. Lab. Med. 121:404.
6. Calandra T., J. Bernhagen, R. A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179:1895.
7. Bernhagen, J., T. Calandra, A. Cerami, and R. Bucala. 1994. Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemia. Trends Microbiol. 2:198.
8. Bucala, R. 1994. MIF, a previously unrecognized pituitary hormone and macrophage cytokine, is a pivotal mediator in endotoxic shock. Circ. Shock 44:35.
9. Bucala, R. 1994. Identification of MIF as a new pituitary hormone and macrophage cytokine and its role in endotoxic shock. Immunol. Lett. 43:23.
10. Bernhagen, J., T. Calandra, and R. Bucala. 1994. The emerging role of MIF in septic shock and infection. Biotherapy 8:123.
11. Calandra, T., and R. Bucala. 1995-96. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. J. Inflamm. 47:39.
12. Rosengren, E., R. Bucala, P. Aman. L. Jacobsson, G. Odh, C. N. Metz, and H. Rorsman. 1996. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol. Med. 2:143.
13. Kleemann, R., A. Kapumiotu, R. W. Frank, A. Gessner, R. Mischke, S. Jüttner, H. Brunner, and J. Bernhagen. 1998. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J. Mol. Biol. 280:85.
14. Calandra, T., J. Bernhagen, C. N. Metz, L. A. Spiegel, M. Bacher, T. Donnelly, A. Cerami, and R. Bucala. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68.
15. Donnelly, S. C., C. Haslett, P. T. Reid, I. S. Grant, W. A. Wallace, C. N. Metz, L. J. Bruce, and R. Bucala. 1997. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat. Med. 3:320.
16. Lan, H. Y., M. Bacher, N. Yang, W. Mu, D. J. Nikolic-Paterson, C. Metz, A. Meinhardt, R. Bucala, and R. C. Atkins. 1997. The pathogenetic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J. Exp. Med. 185:1455.
17. David, J. R. 1993. Erratum: important note on on recombinant migration inhibitory factor (rMIF). J. Immunol. 151:5107.
18. David, J. R. 1993. Corrections: immunology. Proc. Natl. Acad. Sci. USA 90:12056.
19. Bogdan, C., A. Gessner, W. Solbach, and M. Röllinghoff. 1996. Invasion, control and persistence of Leishmania parasites. Curr. Opin. Immunol. 8:517.
20. Locksley, R. M. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
21. Bacher, M., C. N. Metz, T. Calandra, K. Mayer, J. Chesney, M. Lohoff, D. Gemsa, T. Donnelly, and R. Bucala. 1996. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. USA 93:7849.
22. Lohoff, M., M. Dirks, P. Rohwer, and M. Röllinghoff. 1989. Studies on the mechanism of polyclonal B cell stimulation by TH2 cells. Eur. J. Immunol. 19:77.
23. Mitchell, R., M. Bacher, J. Bernhagen, T. Pushkarskaya, M. F. Seldin, and R. Bucala. 1995. Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J. Immunol. 154:3863.
24. Bernhagen, J., R. A. Mitchell, T. Calandra, W. Voelter, A. Cerami, and R. Bucala. 1994. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33:14144.
25. Mikulowska, A., C. N. Metz, R. Bucala, and R. Holmdahl. 1997. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J. Immunol. 158:5514.
26. Vieth, M., A. Will, K. Schröppel, M. Röllinghoff, and A. Gessner. 1994. IL-10 inhibits antimicrobial activity against L. major in murine macrophages. Scand. J. Immunol. 40:403.
27. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Weignmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1995. Mice deficient for the 55-kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
28. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641.
29. Solbach, W., K. Forsberg, and M. Röllinghoff. 1986. Effect of T-lymphocyte suppression on the parasite burden in L. major-infected, genetically susceptible BALB/c mice. Infect. Immun. 54:909.
30. Gessner, A., M. Vieth, A. Will, K. Schröppel, and M. Rollinghoff. 1993.Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages. Infect. Immun. 61:4008.
31. Bogdan, C., H. Moll, W. Solbach, and M. Röllinghoff. 1990. Tumor necrosis factor-α in combination with interferon-ã, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur. J. Immunol. 20:1131.
32. Tushinski, R. C., I. T. Oliver, L. J. Guilbert, P. W. Tynan, J. R. Warner, and E. R. Stanley. 1982. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28:71.
33. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407.
34. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
35. Bernhagen, J., T. Calandra, and R. Bucala. 1998. Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J. Mol. Med. 76:151.
36. Lewis, M., L. Tartaglia, A. Lee, G. Bennet, F. Rice, G. Wong, E. Chen, and D. Goeddel. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88:2830.
37. Tartaglia, L. A., M. Rothe, Y. F. Hu, and D. V. Goeddel. 1993. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73:213.
38. Heller, R. A., K. Song, and N. Fan. 1993. Cytotoxity by tumor necrosis factor is mediated by both p55 and p70 receptor. Cell 73:216.
39. Vieira, L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with L. major, but control parasite replication. J. Immunol. 157:827.
40. Miller, A. R., J. Suttles, and R. D. Stout. 1996. Cytokine-priming reduces dependence on TNF-R2 for TNF-α-mediated induction of macrophage nitric oxide generation. J. Interferon Cytokine Res. 16:1055.
41. Doherty, T. M., R. Kastelein, S. Menon, S. Andrade, and R. L. Coffman. 1993. Modulation of murine macrophage function by IL-13. J. Immunol. 151:7151.
42. Barral, A., M. Teixeira, P. Reis, V. Vinhas, J. Costa, H. Lessa, A. L. Bittencourt, S. Reed. E. M. Carvalho, and M. Barral-Netto. 1995. Transforming growth factor-β in human cutaneous leishmaniasis. Am. J. Pathol. 147:947.
43. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
44. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin 10. Annu. Rev. Immunol. 11:165.
45. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosman. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
46. Assoian, R. K., B. E. Fleurdelys, H. C. Stevenson, P. J. Miller, D. K. Madtes, E. W. Raines, R. Ross, and M. B. Sporn. 1987. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84:6020.
47. + T cell clones and peripheral blood T cells. J. Immunol. 149:2378.
48. Theodos, C. M., L. Povinelli, R. Molina, B. Sherry, and R. G. Titus. 1991. Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect. Immun. 59:2839.
49. Bogdan, C., S. Stenger, M. Röllinghoff, and W. Solbach. 1991. Cytokine interactions in experimental cutaneous leishmaniasis: interleukin 4 synergizes with interferon-γ to activate murine macrophages for killing of Leishmania major amastigotes. Eur. J. Immunol. 21:327.
50. Stenger, S., W. Solbach, M. Röllinghoff, and C. Bogdan. 1991. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-α production by macrophages is induced by the synergistic action of interferon (IFN)-γ and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-γ and IL-4. Eur. J. Immunol. 21:1669.
51. Ho, J. L., S. G. Reed, J. Sobel, S. Arruda, S. H. He, E. A. Wick, and K. H. Grabstein. 1992. Interleukin-3 induces antimicrobial activity against Leishmania amazonensis and Trypanosoma cruzi and tumoricidal activity in human peripheral blood-derived macrophages. Infect. Immun. 60:1984.
52. Titus, R. G., B. Sherry, and A. Cerami. 1989. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 170:2097.
53. Green, S. J., R. M. Crawford, J. T. Hockmeyer, M. S. Meltzer, and C. A. Nacy. 1990. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of tumor necrosis factor-α. J. Immunol. 145:4290.
54. Langermans, J. A., M. E. B. van der Hulst, P. H. Nibbering, P. S. Hiemstra, L. Fransen, and R. van Furth. 1992. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J. Immunol. 148:568.
55. Howard, J. G. 1986. Immunological regulation and control of experimental leishmaniasis. Int. Rev. Exp. Pathol. 28:79.
56. + T cells in leishmaniasis. Immunol. Today 10:40.
57. + T-cell subsets in the regulalion of parasite immunity and disease. Immunol. Rev. 112:161.
58. Kobayashi, K., C. Allred, R. Castriotta, and T. Yoshida. 1985. Strain variation of bacillus Calmette-Guerin-induced pulmonary granuloma formation is correlated with anergy and the local production of migration inhibition factor and interleukin 1. Am. J. Pathol. 119:223.
59. Goebeler, M., J. Gutwald, J. Roth, and C. Sorg. 1991. The severity of irritant contact dermalitis in various strains of mice correlates with endothelial expression of migration inhibitory factor (MIF). Arch. Dermatol Res. 283:246.
60. Shimizu, T., A. Ohkawara, J. Nishihira, and W. Sakamoto. 1996. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS. Lett. 381:199.
61. Bacher, M., A. Meinhardt, H. Y. Lan, W. Mu, C. N. Metz, J. A. Chesney. T. Calandra, D. Gemsa, T. Donnelly, R. C. Atkins, and R. Bucala. 1997. Migration inhibitory factor expression in experimentally induced endotoxemia. Am. J. Pathol. 150:235.
62. Laskay, T., A. Diefenbach, M. Röllinghoff, and W. Solbach. 1995. Early parasite containment is decisive for resistance to L. major infection. Eur. J. Immunol. 25:2220.
63. Bernhagen, J., M. Bacher, T. Calandra, C. N. Metz, S. B. Doty, T. Donnelly, and R. Bucala. 1996. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J. Exp. Med. 183:277.